BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37268989)

  • 1. The direct prognosis comparison of
    Liang Z; Yuliang C; Zhu M; Zhou Y; Wu X; Li H; Fan B; Zhou Z; Yan W
    Eur J Med Res; 2023 Jun; 28(1):181. PubMed ID: 37268989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Risk Prostate Cancer.
    Ciezki JP; Weller M; Reddy CA; Kittel J; Singh H; Tendulkar R; Stephans KL; Ulchaker J; Angermeier K; Stephenson A; Campbell S; Haber GP; Klein EA
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):962-975. PubMed ID: 28333019
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhou Z; Yan W; Zhou Y; Zhang F; Li H; Ji Z
    Oncol Lett; 2019 Jul; 18(1):72-80. PubMed ID: 31289474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of radical prostatectomy versus low-dose-rate brachytherapy in patients with intermediate-risk prostate cancer: Propensity score matched comparison.
    Urabe F; Miki K; Kimura T; Sasaki H; Tashiro K; Iwatani K; Matsukawa A; Aikawa K; Tsusumi Y; Morikawa M; Minato K; Sato S; Takahashi H; Aoki M; Egawa S
    Prostate; 2023 Feb; 83(2):135-141. PubMed ID: 36176043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer.
    Takeuchi S; Iinuma K; Nakane K; Nakano M; Kawase M; Kawase K; Takai M; Kato D; Mori T; Takano H; Kumano T; Matsuo M; Koie T
    Curr Oncol; 2023 Feb; 30(3):2792-2800. PubMed ID: 36975425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate Cancer.
    Goy BW; Burchette R; Soper MS; Chang T; Cosmatos HA
    Urology; 2020 Feb; 136():180-189. PubMed ID: 31704459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Oncological and Functional Outcomes of Brachytherapy and Radical Prostatectomy for Localized Prostate Cancer.
    Wang F; Luan Y; Fan Y; Huang T; Zhu L; Lu S; Tao H; Sheng T; Chen D; Ding X
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295548
    [No Abstract]   [Full Text] [Related]  

  • 9. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.
    Kupelian PA; Potters L; Khuntia D; Ciezki JP; Reddy CA; Reuther AM; Carlson TP; Klein EA
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):25-33. PubMed ID: 14697417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative Blood Transfusion as a Significant Predictor of Biochemical Recurrence and Survival after Radical Prostatectomy in Patients with Prostate Cancer.
    Kim JK; Kim HS; Park J; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2016; 11(5):e0154918. PubMed ID: 27159369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical prostatectomy versus external-beam radiotherapy for localized prostate cancer: long-term effect on biochemical control-in search of the optimal treatment.
    González-San Segundo C; Herranz-Amo F; Alvarez-González A; Cuesta-Álvaro P; Gómez-Espi M; Paños-Fagundo E; Santos-Miranda JA
    Ann Surg Oncol; 2011 Oct; 18(10):2980-7. PubMed ID: 21431406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose rate brachytherapy for men with localized prostate cancer.
    Peinemann F; Grouven U; Hemkens LG; Bartel C; Borchers H; Pinkawa M; Heidenreich A; Sauerland S
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008871. PubMed ID: 21735436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience.
    Sylvester JE; Grimm PD; Wong J; Galbreath RW; Merrick G; Blasko JC
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):376-81. PubMed ID: 20864269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
    Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
    Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis.
    Hayashi N; Osaka K; Muraoka K; Hasumi H; Makiyama K; Kondo K; Nakaigawa N; Yao M; Mukai Y; Sugiura M; Takano S; Ito E; Kaizu H; Koike I; Hata M; Taguri M; Miyoshi Y; Izumi K; Kawahara T; Uemura H
    World J Urol; 2020 Oct; 38(10):2477-2484. PubMed ID: 31875247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer.
    Tsumura H; Tanaka N; Oguchi T; Owari T; Nakai Y; Asakawa I; Iijima K; Kato H; Hashida I; Tabata KI; Satoh T; Ishiyama H
    Radiat Oncol; 2022 Apr; 17(1):71. PubMed ID: 35410307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis.
    Wang Z; Ni Y; Chen J; Sun G; Zhang X; Zhao J; Zhu X; Zhang H; Zhu S; Dai J; Shen P; Zeng H
    World J Surg Oncol; 2020 Feb; 18(1):42. PubMed ID: 32093688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Biochemical Control of a Prospective Cohort of Prostate Cancer Patients Treated With Interstitial Brachytherapy Versus Radical Prostatectomy.
    Sanmamed N; Locke G; Crook J; Liu A; Raman S; Glicksman R; Chung P; Berlin A; Fleshner N; Helou J
    Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):262-268. PubMed ID: 36737311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome comparison of radical prostatectomy versus seed brachytherapy for clinically localized prostate cancer using two biochemical recurrence definitions.
    Zhu XH; Zhang F; Liu ZN; He JD; Li ZA; Ma LL; Huang Y; Lu J
    BMC Surg; 2023 Aug; 23(1):253. PubMed ID: 37635216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.